Welcome to Bio-GAIN

Funding Organisations

Research funding in Germany is provided by government bodies, various organisations, including many of the large non-university research institutions, and industry. Below you will find a list of German funding organisations. More...

Bioeconomy

The better we can describe and understand the elements and structure of biological systems in their complexity and predict their reaction to external factors, the more will we be able to use them for technologies that benefit humankind and the environment. More...

Bi- and multilateral cooperation in education and research

The Federal Ministry of Education and Research cooperates with individual states on many interdisciplinary projects. Direct cooperation makes it possible to devise projects which are tailored to the special situation in each country and to its relations with Germany. More...

German-Russian Year of Science

Federal Minister of Research Prof. Dr. Annette Schavan and her Russian counterpart, Education and Science Minister Andrej Fursenko, announced that 2011 is to be the German-Russian Year of Science in Yekaterinenburg on 15 July. More....

National Research Strategy BioEconomy 2030

With the "National Research Strategy BioEconomy 2030", the Federal Government is laying the foundation for realizing a vision of a sustainable bio-based economy by 2030 which produces sufficient healthy food to feed the world and supplies quality products made from renewable resources. More...

German Funding Programmes: an Overview

This brochure provides a good overview of a selection of funding opportunities available for international students, graduates, postdocs, scientists and researchers offered by various institutions and organisations. More ...

The Pharmaceutical Industry in Germany

Our health is the most precious thing we have. In this respect, innovative and effective pharmaceuticals are of particular importance. Germany offers the perfect location for research, production and sales of world-class pharmaceuticals. It benefi ts from internationally renowned scientists, world-class research and immediate market access to pharmaceuticals. More...

BIOMEVA GmbH, Your Good Manufacturing Partner

The company is dedicated to the current Good Manufacturing Practice (cGMP)production of biologics and therapeutic proteins for the biopharmaceutical industry. Our production facility and extensive technical expertise meet the quality requirements for manufacturing active pharmaceutical ingredients and assure regulatory approval of APIs. More...

c-LEcta announces a license agreement with DSM Pharmaceutical Products

which grants DSM rights to c-LEcta’s proprietary alcohol dehydrogenases for enzyme-screening programs and development of sustainable manufacturing routes for producing pharmaceutical active ingredients and intermediates. DSM will also provide commercialization of sustainable enzyme-based manufacturing routes for c-LEcta. More...

Fresenius Biotech’s ATG-Fresenius S approved for GVHD prophylaxis in stem cell transplantations in Germany

Fresenius Biotech is the first company in Germany to receive Paul-Ehrlich-Institut approval to use a polyclonal antibody in stem cell transplantations. As a result, the preparation − ATG-Fresenius S − can be used in the indication “prophylaxis of graft-versus-host disease (GVHD) for unrelated stem cell transplant donors in adults“. More...

BiobasedWorld at ACHEMA 2012

June18-22, 2012, Frankfurt am Main, Germany

BiobasedWorld at ACHEMA is the venue where the bio-economy becomes visible. Experience first-hand the vibrant community that is constantly driving forward global projects focused on biomass, bio-based chemicals, biofuels, biogas and biorefinery. This event will allow you to meet key players from the bio-based value chain. Discuss new technologies, processes, latest developments and ideas at one time in one place. More...